SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is currently trending as investors debate whether the asset is a deep-value opportunity or a failing project amid a broader, painful drawdown in the altcoin sector. While many community members are frustrated by the downward price action and lack of recovery, others are actively accumulating tokens, citing strong network fundamentals and real-world usage as reasons for optimism despite the current market sentiment.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is seeing heightened community engagement as investors debate the potential for a long-term recovery versus concerns over its massive circulating supply and performance compared to newer meme coins. Many users are actively discussing its price action relative to other tokens and debating the validity of its ecosystem utility.

TokenOS is the world’s most advanced AI-powered Web3 development platform, designed to turn natural language prompts into fully functional, production-ready blockchain applications. From simple tokens and memecoins to complex DeFi protocols, TokenOS automates the creation, deployment, and auditing of smart contracts and dApps with enterprise-grade reliability. By combining advanced language models with blockchain infrastructure, TokenOS removes the barriers of technical expertise, making Web3 development accessible to everyone. With instant deployment, built-in security best practices, and cross-chain support on the roadmap, TokenOS empowers entrepreneurs, developers, and creators to launch tokenized businesses and decentralized applications in seconds.

TokenOS AI

TokenOS AI is gaining momentum as investors spotlight its v4 launch and revenue-sharing model that distributes compute network profits to node runners and stakers. The community is actively discussing a potential supply shock, citing that a significant majority of the token supply is currently locked in long-term staking.

Direxion Shares ETF Trust - Direxion Daily TSLA Bull 2X ETF

Direxion Daily TSLA Bull 2X Shares

The stock is seeing intense activity driven by high-beta volatility and ongoing speculation regarding Tesla's future valuation, particularly around the potential for a massive merger or synergies with SpaceX. Community sentiment is deeply divided, with traders utilizing the leveraged ETF to capitalize on aggressive price swings through options strategies, while others debate the long-term structural validity of the ticker amid frequent, sentiment-driven market shifts.

Teradyne, Inc. engages in the development and sale of automatic test systems. It operates through the following business segments: Semiconductor Test, Robotics, and All Other. The Semiconductor Test segment designs, manufactures, and markets semiconductor test products and services. The Robotics segment includes operations related to the design, manufacturing, and marketing of collaborative robotic arms, autonomous mobile robots, and advanced robotic control software. The company was founded by Alexander V. d'Arbeloff and Nicholas DeWolf in 1960 and is headquartered in North Reading, MA.

Teradyne, Inc.

Teradyne is trending as part of a high-profile cohort of five stocks joining the NASDAQ-100, which has triggered a wave of institutional attention and forced passive index buying. Community discussion is focused on the validation this inclusion provides for Teradyne's role in the AI infrastructure and semiconductor testing supply chain, alongside debates about its long-term quality and upside potential compared to other recent additions.

Re is an internet-native marketplace for insurance capital. It connects eligible capital providers with fully collateralized reinsurance activity conducted through licensed insurance entities. Blockchain infrastructure makes collateral, reserves, and selected operating data verifiable onchain. RE is the governance token of the Re Protocol. It governs protocol upgrades, technical permissions, committee formation, reporting standards, incentive policy, and governance procedures. Underwriting, claims, pricing, reserve decisions, and regulated operations remain with qualified professionals and licensed entities.

RE is capturing investor attention following its recent listings on major exchanges, driving speculation around its role in the real-world asset sector and its application in decentralized reinsurance markets. The community is actively debating the token's long-term utility, monitoring its ability to hold support levels, and analyzing the impact of its limited circulating supply.

Chip

Chip is experiencing significant volatility and high trading volume as investors debate its role as a decentralized financing layer for AI infrastructure. While supporters highlight its GPU-backed lending model and active protocol development, skeptics express concerns over token supply dynamics and frequent price fluctuations.

Dave, Inc. is a digital banking service. Its products include a budgeting tool to help members manage their upcoming bills to avoid overspending, cash advances through its flagship ExtraCash product to help members avoid punitive overdraft fees, a Side Hustle product, where Dave helps connect members with supplemental work opportunities, and Dave Banking, a modern checking account experience with valuable tools for building long-term financial health. The company was founded by Jason Wilk, Paras Chitrakar, and John Wolanin in October 2015 and is headquartered in Los Angeles, CA.

Dave Inc - Ordinary Shares - Class A

Dave Inc

Dave Inc. is trending as investors weigh strong growth metrics and AI-driven underwriting performance against recent price volatility and sector-wide regulatory concerns. The community remains focused on the company's aggressive share repurchase programs, valuation relative to its fintech peers, and technical setups that traders are closely watching for potential breakout signals.

Bonk is a dog-themed memecoin on the Solana blockchain, launched on Christmas Day 2022 to revitalize the Solana community following the FTX collapse. Created by an anonymous team of 22 Solana developers and builders, Bonk distributed 50% of its total 100 trillion token supply via airdrop to community members including NFT collectors, developers, and artists.   The project positions itself as "the first Solana dog coin for the people, by the people," explicitly rejecting venture capital backing in favor of grassroots community ownership. What sets Bonk apart from other memecoins is its combination of fair launch mechanics, extensive ecosystem integration, and active deflationary strategy.   Built on Solana, BONK benefits from fast transaction speeds and low fees that make it practical for everyday use. Native products include LetsBonk.fun (a memecoin launchpad that briefly became Solana's market leader in 2025, surpassing Pump.fun with over 78% market share), BonkSwap (a decentralized exchange) and BonkBot (a Telegram trading bot with built-in burn mechanics).   BONK is available across 10 blockchain networks and listed on major exchanges including Binance, Coinbase, Kraken, and Robinhood. Governance is handled by BonkDAO, which holds 15% of the token supply and makes decisions through on-chain voting.   The community has organized several major burn events, most notably the December 2024 BURNmas campaign that destroyed 1.69 trillion tokens worth over $50 million. In September 2025, Nasdaq-listed Safety Shot, Inc. formed BONK Holdings LLC and acquired over 2.5% of the circulating supply (valued at $55-63 million), making BONK one of the first memecoins to attract formal corporate treasury adoption. Core contributor Nom was appointed to Safety Shot's board, and the company holds a 10% revenue share in LetsBonk.fun.  As with all memecoins, BONK is a highly speculative asset with substantial volatility. Its value is primarily driven by community sentiment, social media momentum, and meme culture rather than traditional utility.   The anonymous team, while common in the memecoin space, means investors should exercise appropriate caution. Despite these risks, Bonk has established itself as one of the most successful community-driven tokens in the Solana ecosystem, approaching 1 million unique holders and expanding from a simple memecoin into meaningful DeFi infrastructure.

BONK

BONK is trending as community members aggressively debate its long-term potential against newer meme coins, with ongoing discussions revolving around market sentiment, the broader Solana ecosystem, and vocal calls for increased community-driven buying pressure.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is experiencing a sharp rally driven by investor optimism surrounding its AI-powered diagnostic technology and a strategic partnership with Midjourney. While long-term bulls are focused on the transformative potential of the company's semiconductor-based ultrasound chips and clinical pipeline, the stock is seeing intense debate as skeptics warn of high valuations, persistent cash burn, and the high probability of a profit-taking pullback after such rapid price appreciation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ocular Therapeutix vs. Prime Medicine: Which Healthcare Stock Is a Better Buy in 2026?

Key PointsOcular Therapeutix is transitioning into a major player in the retinal disease market with its lead program, Axpaxli...

Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates

Prime Medicine, Inc. (PRME) delivered earnings and revenue surprises of -15.99% and -45.13%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

RenovoRx, Inc. (RNXT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

RenovoRx (RNXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Harmony Biosciences Holdings, Inc. (HRMY) Q1 Earnings and Revenues Miss Estimates

Harmony Biosciences (HRMY) delivered earnings and revenue surprises of -27.94% and -3.18%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Prime Medicine (NASDAQ:PRME) Upgraded to Sell at Wall Street Zen

Wall Street Zen raised shares of Prime Medicine from a "strong sell" rating to a "sell" rating in a research note on Tuesday...

Prime Medicine (NASDAQ:PRME) Stock Rating Lowered by Wall Street Zen

Wall Street Zen downgraded shares of Prime Medicine from a "sell" rating to a "strong sell" rating in a research report on Monday...

Prime Medicine, Inc. (NASDAQ:PRME) Given Average Rating of "Moderate Buy" by Brokerages

Prime Medicine, Inc. (NASDAQ:PRME - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the nine brokerages that are covering the firm, Marketbeat reports. One analyst...

Wall Street Zen Upgrades Prime Medicine (NASDAQ:PRME) to Sell

Wall Street Zen upgraded Prime Medicine from a "strong sell" rating to a "sell" rating in a research note on Sunday...

Sumitomo Mitsui Trust Group Inc. Sells 384,418 Shares of Prime Medicine, Inc. $PRME

Sumitomo Mitsui Trust Group Inc. lowered its holdings in Prime Medicine, Inc. (NASDAQ:PRME - Free Report) by 10.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities...

Prime Medicine Appoints Svetlana Makhni As Chief Financial Officer

(RTTNews) - Prime Medicine, Inc. (PRME), a developer of a new class of differentiated one-time curative genetic therapies, said on Thursday that it has appointed Svetlana Makhni as Chief Financial...

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.

Prime Medicine Inc

Citi Downgrade Sparks Retail Chatter On Prime Medicine Amid Cash Runway Uncertainty

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.26	--	--	N/A
Q1 '26	-$0.25	-$0.28	-11.59%	MISSED
Q4 '25	-$0.25	-$0.22	10.44%	BEAT
Q3 '25	-$0.25	-$0.32	-26.51%	MISSED
Q2 '25	-$0.35	-$0.41	-16.75%	MISSED

PRMEPrime Medicine Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings

Latest PRME News